Search research articles
Contact Us
Filters
Showing results (31-40 of 103) with videos related to
Page
of 11
Sort By:
Clinical Journal of Gastroenterology
|
June 30, 2022
Long-term survival with sorafenib-based multidisciplinary treatment for Vp4 hepatocellular carcinoma: a case report
Hibiki Narita, Hideto Kawaratani, Akihiko Shibamoto, et al.
BMC Gastroenterology
|
July 9, 2021
Small intestinal follicular lymphoma induced by methotrexate: a case report
Yui Osaki, Hideto Kawaratani, Hiroki Kachi, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
June 5, 2023
Glucagon-like peptide-1 receptor agonist, semaglutide attenuates chronic liver disease-induced skeletal muscle atrophy in diabetic mice
Satoshi Iwai, Kosuke Kaji, Norihisa Nishimura, et al.
Microorganisms
|
June 25, 2020
Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis
Yuki Tsuji, Kosuke Kaji, Mitsuteru Kitade, et al.
Biology
|
February 25, 2023
The Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity: Usefulness as a Prognostic Biomarker in Acute-on-Chronic Liver Failure
Hiroaki Takaya, Tadashi Namisaki, Masahide Enomoto, et al.
World Journal of Gastroenterology
|
August 2, 2024
Effects of elafibranor on liver fibrosis and gut barrier function in a mouse model of alcohol-associated liver disease
Aritoshi Koizumi, Kosuke Kaji, Norihisa Nishimura, et al.
International Journal of Molecular Medicine
|
June 10, 2022
Rifaximin enhances the L‑carnitine‑mediated preventive effects on skeletal muscle atrophy in cirrhotic rats by modulating the gut‑liver‑muscle axis
Koji Murata, Kosuke Kaji, Norihisa Nishimura, et al.
The Journal of Nutritional Biochemistry
|
September 30, 2023
Vitamin D deficiency exacerbates alcohol-related liver injury via gut barrier disruption and hepatic overload of endotoxin
Akihiko Shibamoto, Kosuke Kaji, Norihisa Nishimura, et al.
International Journal of Molecular Sciences
|
July 29, 2025
Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut-Liver Axis and Epiregulin-IL-8-Associated Angiogenesis
Naoki Nishimura, Kosuke Kaji, Norihisa Nishimura, et al.
Heliyon
|
October 14, 2024
Cabozantinib prevents the progression of metabolic dysfunction-associated steatohepatitis by inhibiting the activation of hepatic stellate cell and macrophage and attenuating angiogenic activity
Takuya Matsuda, Kosuke Kaji, Norihisa Nishimura, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 103) with videos related to
Sort By:
Page
of 11
Clinical Journal of Gastroenterology
|
June 30, 2022
Long-term survival with sorafenib-based multidisciplinary treatment for Vp4 hepatocellular carcinoma: a case report
Hibiki Narita, Hideto Kawaratani, Akihiko Shibamoto, et al.
BMC Gastroenterology
|
July 9, 2021
Small intestinal follicular lymphoma induced by methotrexate: a case report
Yui Osaki, Hideto Kawaratani, Hiroki Kachi, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
June 5, 2023
Glucagon-like peptide-1 receptor agonist, semaglutide attenuates chronic liver disease-induced skeletal muscle atrophy in diabetic mice
Satoshi Iwai, Kosuke Kaji, Norihisa Nishimura, et al.
Microorganisms
|
June 25, 2020
Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis
Yuki Tsuji, Kosuke Kaji, Mitsuteru Kitade, et al.
Biology
|
February 25, 2023
The Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity: Usefulness as a Prognostic Biomarker in Acute-on-Chronic Liver Failure
Hiroaki Takaya, Tadashi Namisaki, Masahide Enomoto, et al.
World Journal of Gastroenterology
|
August 2, 2024
Effects of elafibranor on liver fibrosis and gut barrier function in a mouse model of alcohol-associated liver disease
Aritoshi Koizumi, Kosuke Kaji, Norihisa Nishimura, et al.
International Journal of Molecular Medicine
|
June 10, 2022
Rifaximin enhances the L‑carnitine‑mediated preventive effects on skeletal muscle atrophy in cirrhotic rats by modulating the gut‑liver‑muscle axis
Koji Murata, Kosuke Kaji, Norihisa Nishimura, et al.
The Journal of Nutritional Biochemistry
|
September 30, 2023
Vitamin D deficiency exacerbates alcohol-related liver injury via gut barrier disruption and hepatic overload of endotoxin
Akihiko Shibamoto, Kosuke Kaji, Norihisa Nishimura, et al.
International Journal of Molecular Sciences
|
July 29, 2025
Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut-Liver Axis and Epiregulin-IL-8-Associated Angiogenesis
Naoki Nishimura, Kosuke Kaji, Norihisa Nishimura, et al.
Heliyon
|
October 14, 2024
Cabozantinib prevents the progression of metabolic dysfunction-associated steatohepatitis by inhibiting the activation of hepatic stellate cell and macrophage and attenuating angiogenic activity
Takuya Matsuda, Kosuke Kaji, Norihisa Nishimura, et al.
Page
of 11